Shai Meretzki, founder and CEO of Bonus Biogroup told The Algemeiner. “The ability to have a therapy which specifically heals severe COVID-19 patients and gets them out of hospitals is amazing, because it means that we can live with the virus.”
With one sample of cells, 45,000 patients can be treated, according to Meretzki.